Navigation Links
WuXi PharmaTech Announces First-Quarter 2010 Results
Date:5/11/2010

ange of $310-320 million, which represents 15-19% growth -- Growth in net revenues of China-based Laboratory Services of 13-16% -- Growth rate of net revenues of U.S.-based Laboratory Services of mid single digits -- Growth of net revenues of Manufacturing Services of at least 70% -- Decline in GAAP and non-GAAP gross margin of two to five percentage points -- Growth in GAAP and non-GAAP operating income in the upper end of the previous range of 0% to 10% -- Capital expenditures of $50-60 million, similar to the 2009 level -- Effective tax rate of 13-15%

The Company provides the following guidance for second-quarter 2010 performance:

    -- Total net revenues of $76-78 million
    -- Year-over-year growth in net revenues of China-based Laboratory
       Services of 16-18%
    -- GAAP and non-GAAP gross margins better than first-quarter 2010 GAAP and
       non-GAAP gross margins, which were 37.7% and 39.8%, respectively

"As we prepare to combine our operations with those of Charles River Laboratories, we remain focused on providing the highest level of service to our customers," Dr. Ge Li concluded. "The new Charles River Laboratories will be the first global contract research organization offering fully integrated early-stage drug discovery and development services. We continue to believe that trends toward greater outsourcing and offshoring of pharmaceutical, biotechnology, and medical device research and development will continue for years to come, and that our company is positioned well to benefit from these trends."



                          WUXI PHARMATECH (CAYMAN) INC.
                      UNAUDITED CONSOLIDATED BALANCE SHEETS
     (in thousands of U.S. dollars, except ordinary share, ADS and par value
                                      data)
                          
'/>"/>
SOURCE  WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 

Related medicine technology :

1. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
2. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
3. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
6. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
7. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
8. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
9. Jazz Pharmaceuticals Announces Public Offering of Common Stock
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
11. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... India , June 19, 2013 ... Bureau has recently added DrugPatentWatch to ... ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )      ... provides comprehensive information on pharmaceutical, drug ... information supports the critical business functions ...
(Date:6/19/2013)... 2013 DST Health Solutions, LLC (DSTHS), a ... plans, integrated delivery systems, and health care providers, has ... Service (MDMS) has jumped significantly. A ... pricing of medical prescription drug claims, MDMS ... medical drug claims processes. As specialty drug demand grows ...
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... (NYSE Amex: ANX ) announced today that it ... review development plans for ANX-188 (purified poloxamer 188), the Company,s ... ADVENTRX and the FDA discussed a variety of ... as the design of a phase 3 study for the ...
... 1, 2011 Advantage Home Telehealth (ADHT) announced ... to rapidly expand the deployment of the company,s ... open to insurance companies, physician groups, hospitals, clinics, ... interested in improving the quality and cost-effectiveness of ...
Cached Medicine Technology:ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 2ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 3Advantage Home Telehealth Launches Affiliate Program 2
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... in the June 19 online edition of the journal ... from the University of California, San Diego School of ... place when cardiac regeneration occurs in zebrafish after cardiac ... cell lines in the heart are more plastic, or ... thought. , More importantly, the research reveals a novel ...
(Date:6/19/2013)... Ore. A new understanding of the genetic process ... diagnosis of potentially dangerous lesions for some women, and ... anti-viral therapies in certain cases suggesting they could ... , The analysis provides a clearer picture of the ... human papillomavirus sometimes leads to chronic infection and, in ...
(Date:6/19/2013)... Iowa study reveals significant disparities between minority and ... abuse treatment programs. Moreover, these disparities vary widely ... suggest that for most states there,s something amiss," ... and biostatistics. "There are strong racial and ethnic ... substance abuse treatment programs successfully, and those disparities ...
Breaking Medicine News(10 mins):Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... (IEEC) of the Binghamton University has received the ... York State Office of Science, Technology and Academic ... Microelectronics Research in the roll-to-roll format. ,NYSTAR’S ... initiatives, recognized by the New York State, especially ...
... Blue light tends to dissuade sleep, and it may be ... shifts, according to latest research reports. The alertness levels of ... the light they are working under, according to neuroscientist Steven ... ,Light contributes towards the wakefulness of a person. The ...
... the US who are as young as 13 years run the ... risk run by older people. // The study which took into ... were either overweight or about to become so. High blood sugar ... insulin levels were seen in the case of 36% of the ...
... Approaching Menopause? Losing your mind? Just pause and read ... Annual meeting of the International Neuropsychological Society, // suggests ... unforgettable. That means they might have huge difficulties remembering ... ,According to the study team, from the University of ...
... one can smell better when one is upright than when ... better sense of smell when they are sitting or standing. ... the Montreal Neurological Institute said that there is a significant ... ,Researchers at the McGill University institute conducted a ...
... Connecticut will be contacting police officers, school leaders, in ... pandemic influenza were to break out. // Officials belonging ... a situation. The fire department everywhere has to be ... been witness to several epidemics in the past which ...
Cached Medicine News:Health News:$ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle. 2Health News:Menopause pauses memory, posing unforgettable problems 2
Fulgurating Electrode, 3 F...
... The ACMI USA Series ACN-2 Flexible CystoNephroscope ... It is ideal for office practice. The ... accommodates a full range of operating instruments ... outer diameter, and beveled, UltraGlide covered tip ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: